You are here

epilepsy

Stoke faces new doubts in search for ‘Spinraza for epilepsy’

Stoke faces new doubts in search for ‘Spinraza for epilepsy’

BioPharma Dive

Stoke Therapeutics

Dravet syndrome

Flag link:

Neurona’s brain stem cell therapy shows early efficacy in epilepsy

Neurona’s brain stem cell therapy shows early efficacy in epilepsy

Clinical Trials Arena

clinical trials

Flag link:

Cerevel blames Covid for delayed neuroscience studies, says president is leaving

Cerevel blames Covid for delayed neuroscience studies, says president is leaving

Endpoints

Cerevel Therapeutics

Parkinson's Disease

Flag link:

With bigger fish to fry, Eisai unloads US rights to epilepsy drug Fycompa to Catalyst

With bigger fish to fry, Eisai unloads US rights to epilepsy drug Fycompa to Catalyst

Fierce Pharma

Catalyst Pharmaceuticals

Flag link:

Praxis ends year on high with $100M biobucks UCB deal for epilepsy medicine

Praxis ends year on high with $100M biobucks UCB deal for epilepsy medicine

Fierce Biotech

Flag link:

Biohaven fuels up for post-Pfizer future with $302M fundraising, fresh faces in the C-suite

Biohaven fuels up for post-Pfizer future with $302M fundraising, fresh faces in the C-suite

Fierce Biotech

Flag link:

With Pfizer sale in the rearview, Biohaven veers toward Kv7 platform following late-stage trial fails, delays

With Pfizer sale in the rearview, Biohaven veers toward Kv7 platform following late-stage trial fails, delays

Fierce Biotech

Flag link:

Ovid takes a novel approach to gene therapy

Ovid takes a novel approach to gene therapy

EP Vantage

Ovid Therapeutics

Flag link:

Jazz Takes Groundbreaking Epilepsy Drug into Kids in Phase III Trial

Jazz Takes Groundbreaking Epilepsy Drug into Kids in Phase III Trial

BioSpace

clinical trials

Flag link:

After rejection, Azurity gets FDA nod for liquid epilepsy drug

After rejection, Azurity gets FDA nod for liquid epilepsy drug

Fierce Pharma

Flag link:

French court rules against Sanofi in landmark Depakine case

French court rules against Sanofi in landmark Depakine case

Endpoints

Flag link:

FDA tells Praxis it can't move into the clinic just yet for a rare epilepsy drug

FDA tells Praxis it can't move into the clinic just yet for a rare epilepsy drug

Endpoints

Praxis Precision Medicines

Flag link:

Controversial opioid Zohydro ER pulled from the market

Controversial opioid Zohydro ER pulled from the market

Endpoints

Flag link:

Ovid signs license deal with AstraZeneca to expand epilepsy drug pipeline

Ovid signs license deal with AstraZeneca to expand epilepsy drug pipeline

Pharmaceutical Business Review

Ovid Therapeutics

small molecule drugs

Flag link:

Canada's Xenon touts out-of-the-blue win for its daily epilepsy pill, sending investors into a frenzy

Canada's Xenon touts out-of-the-blue win for its daily epilepsy pill, sending investors into a frenzy

Endpoints

clinical trials

Flag link:

Neuroelectrics gets $17M for new take on electrical therapy for epilepsy, depression

Neuroelectrics gets $17M for new take on electrical therapy for epilepsy, depression

MedCity News

electrical therapy

Flag link:

Jazz Pharma to acquire GW Pharma for $7.2 billion, adding CBD-based treatment for severe epilepsy

Jazz Pharma to acquire GW Pharma for $7.2 billion, adding CBD-based treatment for severe epilepsy

Stat

Flag link:

UCB backs epilepsy-focused digital heath startup Nile AI

UCB backs epilepsy-focused digital heath startup Nile AI

Pharmaforum

artificial intelligence

Flag link:

In quick start to new year's M&A, Arvelle Therapeutics hands reins to Angelini as it nears EU approval for cenobamate

In quick start to new year's M&A, Arvelle Therapeutics hands reins to Angelini as it nears EU approval for cenobamate

Endpoints

Arvelle Therapeutics

Angelini Pharma

Flag link:

Cerebral Therapeutics announces enrolment of first patient in phase 2b trial in epilepsy

Cerebral Therapeutics announces enrolment of first patient in phase 2b trial in epilepsy

Pharmaceutical Business Review

Cerebral Therapeutics

clinical trials

Flag link:

Pages